HealthSouth Corp.

  • Companies Look to Profit From Changes in the Healthcare Industry

    By Eileen Rojas - July 15, 2013 | Tickers: HCA, HLS, THC, VHS

    Stocks of publicly traded hospitals have gone up since the Supreme Court deemed the Affordable Care Act, commonly referred to as Obamacare, constitutional last year, according to the Economist. Hospitals stand to profit from the flood of newly insured people entering the market and seeking treatment for a variety of ailments.

    And more change is in the air, as hospitals merge and change their business models to stop the runaway more »

  • Should Investors Buy This Specialty Hospital Operator Now?

    By Anh HOANG - July 10, 2013 | Tickers: HLS, KND, SEM

    Since the beginning of the year, Select Medical Holdings (NYSE: SEM) has been declining, from $9.90 per share to only $7.85 per share. To take advantage of the falling price, many famous investors, including Joel Greenblatt, Wilbur Ross, Chuck Royce, and Steven Cohen, have accumulated Select Medical for their own portfolios. Should others follow these successful investors into Select Medical? 

    Consistent growth in revenue and earnings

    Select Medical more »

  • The Real Healthcare Killer

    By Adem Tahiri - June 14, 2013 | Tickers: AHS, HLS, KND

    Healthcare is becoming the David Bowie of the stock market.
     
    Yes, this industry is going through some major ch-ch-changes right now. From day to day this industry is looking a bit different then it did before, but the biggest changes probably aren't where you'd expect.
     
    The biggest change isn't healthcare reform. The industry is actually experiencing much greater turmoil from a severe labor shortage that is set more »
  • OTC Offers Chance for Redemption

    By Nick Slepko - December 24, 2012 | Tickers: BASFY.PK, HLS, NSANY.PK, OTCM

    R. Cromwell Coulson is President, CEO, and a Director of OTC Markets Group (OTCQX:OTCM)(NASDAQOTH: OTCM)[traded on OTCQX] which operates marketplaces for securities with a current combined market capitalization exceeding USD 13 trillion (more than twice the size of NASDAQ, and only a few trillion shy of the NYSE).

    [continued from “I Was a Frustrated Trader”

    Nick Slepko:  What role to ADRs and international companies in general play more »

  • Psychology, Scandals and Selling

    By Adem Tahiri - November 14, 2012 | Tickers: AMD, ABX, CECO, HLS, HPQ, NFLX | Editor's Choice

    One of my favorite books is Jason Zweig’s “Your Money and Your Brain.” Most investing books I’ve read were on nuts and bolts, valuations and the like. But what I’ve always struggled with, is the emotional side of investing, not fundamentals.

    If you haven’t read Mr. Zweig’s book, I highly recommend it as it focuses on topics you may not have read elsewhere. One of more »

  • The Half Trillion Dollar Healthcare Market that Just One Company is Addressing

    By Matthew DiLallo - October 28, 2012 | Tickers: CYH, HCN, HLS, MPW, BX

    Did you know that there is more than $400 billion worth of acute-care hospital real estate in the US?  That real estate is almost entirely owned by cash crunched operators that are facing ever rising costs with an equally fast rising need to perform at the highest level.  Just one company is addressing the growing need to provide capital to these hospital operators by entering into sale-leaseback transactions.  That company more »

  • Warren Buffett Buys More of This Healthcare Stock

    By Meena Krishnamsetty - October 23, 2012 | Tickers: ACHC, DVA, HGR, HLS, MD

    Warren Buffett’s Berkshire Hathaway has continued buying shares of DaVita (NYSE: DVA) in the month of October, including a purchase of over 60,000 shares on October 16. Berkshire had initiated its position in the company in the fourth quarter of 2011, with 2.7 million shares in its portfolio at the end of the year, and then increased its stake further in the first half of the year more »

  • Top Small Cap Fund’s Top Stock Picks

    By Meena Krishnamsetty - September 21, 2012 | Tickers: CSGP, HLS, LTM, LL, WEX

    Mariko Gordon founded Daruma Capital Management in 1995 after having managed portfolios for Valenzuela Capital Management and Royce & Associates. Daruma invests in a concentrated set of long-term stocks that follow a specified list of rules with a preference for smaller-cap stocks. Daruma’s rules include a potential upside of at least 50% over the next two years (and an upside three times the size of the downside) as well as more »

  • A Heath Care Company Hits a Growth Spurt

    By Matthew DiLallo - August 13, 2012 | Tickers: CYH, HCN, HLS, MPW, VTR

    No matter where you stand on the great heath care debate, one thing is sure -- it is going to keep costing us a lot of money to stay healthy.  Compound that with us getting older, heavier and, well, there just seems to always be more of us, and it’s a recipe for profitable industry growth.  So when things ache or pieces break, we’ll continue to go to that more »

  • A Healthy Way to Invest in Real Estate

    By Matthew DiLallo - June 7, 2012 | Tickers: CYH, HCN, HLS, MPW, VTR

    If you’ve read any of my previous articles you know that dividends are very important to my investing philosophy.  One of the best places to find the type of dividends I like is found in a Real Estate Investment Trust (REIT).  I’ll be looking to allocate at least 10% of my “No Drip, No Mess” Portfolio to REITS as this steady income will provide the funds I’ll more »

  • J.P. Morgan Healthcare Conference Schedule: Day One

    By Brandy Betz - January 8, 2012 | Tickers: ARAY, ACOR, A, ALGN, AMRN, AMGN, AMLN, ARTC, BIIB, BMRN, BRKR, CFN, CTRX, CELG, CNC, COV, DNDN, XRAY, EW, ENDP, EPOC, ESRX, GHDX, GILD, HLS, HTWR, HMSY, HGSI, IDXX, IPXL, INCY, IRWD, MCK, MRX, MDT, MR, MOH, MYL, NVS, ONXX, PRX, PRGO, QSII, REGN, RMD, RIGL, SGEN, ST, SIAL, THC, MDCO, THOR, VRTX, VVUS, WAT, WMGI, ZLTQ

    The 30th Annual J.P. Morgan Healthcare Conference kicks off with a full day of presentations from companies that range from global pharmaceutical leaders to small cap novel pharmaceutical developers and health technology manufacturers. The majority of the presentations will be available through live webcasts with archived replay offered later in the day.

    I will be following (and covering) the novel therapeutic companies that have caught my eye. VIVUS (NASDAQ: VVUSmore »)